Invigor Group Limited (ASX:IVO) is pleased to announce its wholly-owned Berlin-based software solutions business Condat AG has been selected as one of the providers of software tools and associated services in a multi-million dollar project at one of the leading public broadcasting companies in Europe.
E-Commerce and Mobile
99 Wuxian Ltd (ASX:NNW) is pleased to provide a trading update for the March 2016 quarter.
iSignthis Ltd (ASX:ISX) is pleased to provide the following business update and Appendix 4C for the quarter ended 31st March 2016.
Leading big data solutions company Invigor Group Limited (ASX:IVO) is pleased to announce its wholly-owned Berlin-based software solutions business Condat AG has won a major contract with one of the leading European operators of wind turbines, delivering a best-in-breed mobile workforce management system based on its Skyware product.
99 Wuxian Ltd (ASX:NNW) present their annual report together with the audited consolidated financial statements for the year ended 31 December 2015.
iSignthis Ltd (ASX:ISX) are pleased to provide an analyst brief presented at Hong Kong - April 2016.
iSignthis Ltd (ASX:ISX) has received executed access agreements, and also finalised and tested its technical integration with Yeepay, and its subsidiary the Beijing Yi HuiJin Information Service Co. Ltd.
Banking & Finance
- 99 Wuxian Ltd (ASX:NNW) iBenefit Secures New Clients and Merchants, Upgrades Platform
- Sayona Mining Ltd (ASX:SYA) Acquisition of Advanced Lithium Deposit in Canada
- 99 Wuxian Ltd (ASX:NNW) March 2016 Quarterly Trading Update
Oil Gas & Energy
- Enterprise Uranium Ltd (ASX:ENU) Private Placement Raises $1 Million
- Enterprise Uranium Ltd (ASX:ENU) Presentation - Sandstone Gold Project
- Petsec Energy Ltd (ASX:PSA) 2016 Chairman's Address to Shareholders
- Regeneus Ltd (ASX:RGS) Potential Japan Licence Deal a STEP Closer
- Regeneus Ltd (ASX:RGS) Australian Research Council Linkage Grant to Progress Stem Cell Research into Treating Chronic Pain
- Regeneus Ltd (ASX:RGS) Enrolment Complete and Positive Safety in Progenza Trial For Osteoarthritis